Interleukin 18

Processing

Cytokines usually contain the signal peptide which is necessary for their extracellular release. However, the IL-18 protein, similar to other IL-1 family members, lacks this signal peptide. Furthermore, similar to IL-1β, IL-18 is produced as a biologically inactive precursor. IL-18 gene encodes for a 193 amino acids precursor, first synthesized as an inactive 24 kDa precursor with no signal peptide, which accumulates in the cell cytoplasm. Similarly to IL-1β, the IL-18 precursor is processed intracellularly by caspase 1 in the NLRP3 inflammasome into its mature biologically active molecule of 18 kDa.

Receptor and signaling

IL-18 receptor consists of the inducible component IL-18Rα, which binds the mature IL-18 with low affinity and the constitutively expressed co-receptor IL-18Rβ. IL-18 binds the ligand receptor IL-18Rα, inducing the recruitment of IL-18Rβ to form a high affinity complex, which signals through the toll/interleukin-1 receptor (TIR) domain. This signaling domain recruits the MyD88 adaptor protein that activates proinflammatory programs and NF-κB pathway. The activity of IL-18 can be suppressed by extracellular interleukin 18 binding protein (IL-18BP) that binds soluble IL-18 with a higher affinity than IL-18Rα thus preventing IL-18 binding to IL-18 receptor. IL-37 is another endogenous factor that suppresses the action of IL-18. IL-37 has high homology with IL-18 and can bind to IL-18Rα, which then forms a complex with IL-18BP, thereby reducing the activity of IL-18. Moreover, IL-37 binds to single immunoglobulin IL-1 receptor related protein (SIGIRR), also known as IL-1R8 or TIR8, which forms a complex with IL-18Rα and induces an anti-inflammatory response. The IL-37/IL-18Rα/IL-1R8 complex activates the STAT3 signaling pathway, decreases NF-κB and AP-1 activation and reduces IFNγ production. Thus, IL-37 and IL-18 have opposing roles and IL-37 can modulate pro-inflammatory effects of IL-18.

Function

IL-18 belongs to the IL-1 superfamily and is produced mainly by macrophages but also by other cell types, stimulates various cell types and has pleiotropic functions. IL-18 is a proinflammatory cytokine that facilitates type 1 responses. Together with IL-12, it induces cell-mediated immunity following infection with microbial products like lipopolysaccharide (LPS). IL-18 in combination with IL-12 acts on CD4, CD8 T cells and NK cells to induce IFNγ production, a type II interferon that plays an important role in activating macrophages and other cells. The combination of IL-18 and IL-12 has been shown to inhibit IL-4 dependent IgE and IgG1 production and enhance IgG2a production in B cells. Importantly, without IL-12 or IL-15, IL-18 does not induce IFNγ production, but plays an important role in the differentiation of naive T cells into Th2 cells and stimulates mast cells and basophils to produce IL-4, IL-13, and chemical mediators such as histamine.

Clinical significance

Apart from its physiological role, IL-18 is also able to induce severe inflammatory reactions, which suggests its role in certain inflammatory disorders such as chronic inflammation and autoimmune disorders. High levels of IL18 have also been described in essential hypertensive subjects

Endometrial IL-18 receptor mRNA and the ratio of IL-18 binding protein to interleukin 18 is significantly increased in adenomyosis patients in comparison to normal people, indicating a role in its pathogenesis.

IL-18 has been implicated as an inflammatory mediator of Hashimoto's thyroiditis, the most common cause of autoimmune hypothyroidism. IL-18 is upregulated by interferon-gamma.

IL-18 has also been found to increase the Alzheimer's disease-associated amyloid-beta production in human neuron cells.

IL-18 is also associated with urine protein excretion which means that it can be marker for assessing the progression of diabetic nephropathy. This interleukin was also significantly elevated in patients with microalbuminuria and macroalbuminuria when it was compared with healthy people and patients with diabetes which have normoalbuminuria.

IL-18 is involved in the neuroinflammatory response after intracerebral hemorrhage.

The single-nucleotide polymorphism (SNP) IL18 rs360719, a genetic variant of the Interleukin-18 (IL-18) gene, revealed a probable role in determining the susceptibility to systemic lupus erythematosus and to be a possible "key factor in the expression of the IL18 gene."

References

References

1. (November 1995). "Cloning of a new cytokine that induces IFN-gamma production by T cells". Nature.
2. (July 1998). "The human interleukin 18 gene IL18 maps to 11q22.2-q22.3, closely linked to the DRD2 gene locus and distinct from mapped IDDM loci". Genomics.
3. (February 1989). "Endotoxin-induced serum factor that stimulates gamma interferon production". Infection and Immunity.
4. (February 2019). "Interleukin-18 in Health and Disease". International Journal of Molecular Sciences.
5. (2019). "IL-1 Family Members in Cancer; Two Sides to Every Story". Frontiers in Immunology.
6. (April 2015). "Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP". Journal of Leukocyte Biology.
7. (June 1998). "Overview of interleukin-18: more than an interferon-gamma inducing factor". Journal of Leukocyte Biology.
8. (January 1997). "Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme". Science.
9. (September 1999). "Interleukin-18". Methods.
10. (January 2018). "Interleukin-18: Biological properties and role in disease pathogenesis". Immunological Reviews.
11. (2018). "Reviews of Interleukin-37: Functions, Receptors, and Roles in Diseases". BioMed Research International.
12. (March 2024). ["TIR8/SIGIRR: an IL-1R/TLR family member with regulatory functions in inflammation and T cell polarization"](https://zenodo.org/record/3419195 }}{{Dead link). Trends in Immunology.
13. "Entrez Gene: IL18 interleukin 18 (interferon-gamma-inducing factor)".
14. (February 2019). "Interleukin-18 in Health and Disease". International Journal of Molecular Sciences.
15. (1 October 2009). "Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus". [[Oxford University Press]].
16. (2019). "Interleukin 10 And 18 Levels in Essential Hypertensives.". Journal of Applied Sciences and Environmental Management.
17. (June 2010). "Eutopic endometrial interleukin-18 system mRNA and protein expression at the level of endometrial-myometrial interface in adenomyosis patients". Fertility and Sterility.
18. (October 2010). "Thyrocyte interleukin-18 expression is up-regulated by interferon-γ and may contribute to thyroid destruction in Hashimoto's thyroiditis". International Journal of Experimental Pathology.
19. (August 2012). "Pro-inflammatory interleukin-18 increases Alzheimer's disease-associated amyloid-β production in human neuron-like cells". Journal of Neuroinflammation.
20. (2015-10-30). "The Expression of Tristetraprolin and Its Relationship with Urinary Proteins in Patients with Diabetic Nephropathy". PLOS ONE.
21. (December 2005). "Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes". Diabetes Care.
22. (2019-06-11). "The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes". PeerJ.
23. (March 2019). "Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhage". Progress in Neurobiology.